
Apple Launches Virtual Health Studies Aiming to Enroll Hundreds of Thousands of Customers
Amid privacy concerns, the tech giant plans to monitor mobility, menstruation and hearing via users’ Apple watches and iPhones
Follow Rebecca Robbins on Twitter @rebeccadrobbins
Amid privacy concerns, the tech giant plans to monitor mobility, menstruation and hearing via users’ Apple watches and iPhones
The social media giant, which has faced scrutiny over its privacy practices in the past, will allow people to find information about health screenings and flu shots
Patients can pay hundreds to thousands of dollars to screen for genetic health risks
Plasma from young people offers “no proven clinical benefit” as a treatment against aging or Alzheimer’s disease, the agency says
Promoters hope efforts will also offer insights into treatments used for humans
In a YouTube video, the researcher announced the birth of twin girls whose genomes he says were modified with CRISPR to prevent HIV infection
Since criminal charges were filed, these may be the most pressing issues
Law enforcement’s use of an open-source DNA ancestry database raises questions about genetic privacy
The SEC complaint alleges that the company misled investors
“There’s no evidence in my mind that it’s going to work”
It hasn’t been compared with traditional drugs or therapy
A company called Kick wants to market to the masses a heart medication that would be used for reversing stage fright. Some medical professionals are getting agitated
Researchers hope blood and brain scans may detect new clues
90 percent of new therapies approved this year had testing outside the U.S. and Canada
An analysis of prescription refill data reveals stark regional differences in medication adherence
Buoyed by Pres. Trump, advocates are pressing for a new safety commission
The president-elect's pick for HHS head supports such a change
The fruity with a hint of double helix assertion is not backed by strong science
Hit by a vicious case, the actor said he wanted to “reboot” his brain
The Federal Trade Commission will be sending out rebates to thousands of Lumosity customers misled by company ads
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account